Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Anderson

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
CNS Spectrums|July 15, 2022
The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depressionVincent Van den Eynde, Wegdan R Abdelmoemin, Magid M Abraham, et al.
BMC Psychiatry|January 23, 2023
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationaleCynthia H Y Fu, Guray Erus, Yong Fan, et al.
Nature. Mental Health|July 1, 2024
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placeboCynthia H Y Fu, Mathilde Antoniades, Guray Erus, et al.
Communications Medicine|November 19, 2025
Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and geneticsWenyi Xiao, Rachel D Woodham, Yuhan Cui, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2026
Age-dependent acceleration of structural brain aging in medication-free major depressive disorder linked to neuroanatomical phenotype findings from COORDINATE-MDD consortiumBhanu Sharma, Pedro L Ballester, Luciano Minuzzi, et al.
Molecular Psychiatry|December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trialsLuca Sforzini, Courtney Worrell, Melisa Kose, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
CNS Spectrums|July 15, 2022
The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depressionVincent Van den Eynde, Wegdan R Abdelmoemin, Magid M Abraham, et al.
BMC Psychiatry|January 23, 2023
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationaleCynthia H Y Fu, Guray Erus, Yong Fan, et al.
Nature. Mental Health|July 1, 2024
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placeboCynthia H Y Fu, Mathilde Antoniades, Guray Erus, et al.
Communications Medicine|November 19, 2025
Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and geneticsWenyi Xiao, Rachel D Woodham, Yuhan Cui, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2026
Age-dependent acceleration of structural brain aging in medication-free major depressive disorder linked to neuroanatomical phenotype findings from COORDINATE-MDD consortiumBhanu Sharma, Pedro L Ballester, Luciano Minuzzi, et al.
Molecular Psychiatry|December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trialsLuca Sforzini, Courtney Worrell, Melisa Kose, et al.
Pageof 9